A Phase 1 study to look at RP-6306 in combination with FOLFIRI as atreatment for Advanced Solid Tumours
Phase 1
- Conditions
- Advanced solid tumoursTherapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2024-511927-32-00
- Lead Sponsor
- Repare Therapeutics USA Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 106
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method